Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| P50CA101451-10 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Cancer Institute (NCI) | NIH |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is an educational intervention study testing the effects of decision aids in promoting patient participation in early stage prostate cancer treatment decision making. The purpose of this study is to compare patient-physician communication between patients who receive a DVD that models patient communication strategies vs. those who do not receive a DVD. All patients will also receive a written decision aid that describes treatment options for early stage prostate cancer. The Investigators hypothesize that the DVD will:
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| DVD Decision Aid | Experimental | Eligible participants receive the written decision aid ("Making the Choice: Deciding What to Do About Early Stage Prostate Cancer") AND the DVD decision aid ("Discussing the Choice: Talking with your Doctor about Early Stage Prostate Cancer"), which provides instruction and recommendations on how to participate in shared decision making with one's physician. |
|
| Written Decision Aid | Active Comparator | Eligible participants receive the written decision aid ("Making the Choice: Deciding What to Do About Early Stage Prostate Cancer") alone. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| DVD Decision Aid | Behavioral | The decision aid, "Discussing the Choice: Talking with your Doctor about Early Stage Prostate Cancer" is a DVD modeling patient communication strategies. The DVD includes vignettes with actors depicting patient-physician discussions of prostate cancer treatments. In these vignettes, the patient models communication strategies designed to facilitate patient activation. |
| Measure | Description | Time Frame |
|---|---|---|
| Self-efficacy for discussing preferences (intention) | 14 item survey instrument | Time 1 (baseline) |
| Self-efficacy for discussing preferences (intention) | 14 item survey instrument | Time 2 (post-intervention, an average of 3 days after Time 1 baseline) |
| Self-efficacy for discussing preferences (actual) | 14 item survey instrument | Time 3 (post-diagnosis, an average of 1 month after Time 1 baseline) |
| Measure | Description | Time Frame |
|---|---|---|
| Preference for shared decision making | 1 item survey instrument | Time 1 (baseline) |
| Preference for shared decision making | 1 item survey instrument |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Angela T Fagerlin, PhD | University of Michigan | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Michigan Health System | Ann Arbor | Michigan | 48109 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 35727324 | Derived | Fridman I, Ubel PA, Kahn VC, Fagerlin A. Association of quantitative information and patient knowledge about prostate cancer outcomes. Health Psychol. 2022 Jul;41(7):484-491. doi: 10.1037/hea0001196. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D011471 | Prostatic Neoplasms |
| ID | Term |
|---|---|
| D005834 | Genital Neoplasms, Male |
| D014565 | Urogenital Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Written decision aid | Behavioral | A written decision aid entitled "Making the Choice: Deciding What to Do About Early Stage Prostate Cancer" that describes treatment options for early stage prostate cancer. |
|
| Time 2 (post-intervention, an average of 3 days after Time 1 baseline) |
| Prostate cancer related knowledge | 10 item survey instrument | Time 1 (baseline) |
| Prostate cancer related knowledge | 10 item survey instrument | Time 2 (post-intervention, an average of 3 days after Time 1 baseline) |
| Prostate cancer related knowledge | 12 item survey instrument | Time 3 (post-diagnosis, an average of 1 month after Time 1 baseline) |
| Prostate cancer related anxiety | 6 item survey instrument | Time 1 (baseline) |
| Prostate cancer related anxiety | 6 item survey instrument | Time 2 (post-intervention, an average of 3 days after Time 1 baseline) |
| Prostate cancer related anxiety | 6 item survey instrument | Time 3 (post-diagnosis, an average of 1 month after Time 1 baseline) |
| Prostate cancer related anxiety | 7 item survey instrument | Time 4 (6 months post diagnosis) |
| Treatment preference | 1 item survey instrument | Time 2 (post-intervention, an average of 3 days after Time 1 baseline) |
| Treatment decision | 2 item survey instrument | Time 3 (post-diagnosis, an average of 1 month after Time 1 baseline) |
| Treatment decision | 2 item survey instrument | Time 4 (6 months post diagnosis) |
| Decisional regret | 5 item survey instrument | Time 4 (6 months post diagnosis) |
| Preference for shared decision making | 1 item survey instrument | Time 3 (post-diagnosis, an average of 1 month after Time 1 baseline) |
| Preference for shared decision making | 1 item survey instrument | Time 4 (6 months post diagnosis) |
| D005832 |
| Genital Diseases, Male |
| D000091662 | Genital Diseases |
| D000091642 | Urogenital Diseases |
| D011469 | Prostatic Diseases |
| D052801 | Male Urogenital Diseases |